Christopher Warren to Cover Medical Devices
ARLINGTON, Va., Nov. 2 /PRNewswire-FirstCall/ -- FBR Capital Markets Corporation (Nasdaq: FBCM) (FBR Capital Markets) today announced that Christopher Warren has joined FBR Capital Markets as a Senior Vice President and Senior Research Analyst within its healthcare group and will focus on the medical device sector.
"Chris has nearly ten years of experience in equity research, and we value the disciplined, rigorous method he's developed as an analyst over that period," said David Khani, Director of Research. "We continue to expand our team of analysts, and the addition of coverage for medical device equities will complement the expertise of our healthcare group. FBR Capital Markets Research has been investing in its growth and value products and continues to expand these platforms."
Before joining FBR Capital Markets, Mr. Warren was a senior medical device analyst with SunTrust Robinson Humphrey. Prior to that, he was a senior medical device analyst with Janney Montgomery Scott. Mr. Warren began his career as an investment banking analyst at Credit Suisse First Boston.
Mr. Warren will be based in FBR Capital Markets' New York Office.
FBR Capital Markets Corporation (FBR Capital Markets), a majority-owned subsidiary of Friedman, Billings, Ramsey Group, Inc. (FBR), provides investment banking*, merger and acquisition advisory services*, institutional brokerage*, asset management and private wealth services. FBR Capital Markets focuses capital and financial expertise on eight industry sectors: consumer, diversified industrials, energy & natural resources, financial institutions, healthcare, insurance, real estate, and technology, media & telecom. FBR is headquartered in the Washington, D.C. metropolitan area with offices in Arlington, VA; Boston; Dallas; Houston; Irvine; London, England; New York; San Francisco; and Sydney, Australia. For more information, please visit http://www.fbrcapitalmarkets.com.
*Friedman, Billings, Ramsey & Co., Inc.
|SOURCE FBR Capital Markets Corporation|
Copyright©2007 PR Newswire.
All rights reserved